NASDAQ:RARX - Ra Pharmaceuticals News Headlines

Sign in or create an account to add this stock to your watchlist.
$22.57 -1.93 (-7.88 %)
(As of 05/20/2019 04:00 PM ET)
Previous Close$24.50
Today's Range$22.49 - $24.62
52-Week Range$5.86 - $27.68
Volume364,900 shs
Average Volume437,591 shs
Market Capitalization$954.78 million
P/E RatioN/A
Dividend YieldN/A
Beta0.79

Headlines

Ra Pharmaceuticals (NASDAQ RARX) News Headlines

Source:
DateHeadline
Ra Pharmaceuticals (RARX) Price Target Raised to $42.00 at SunTrust BanksRa Pharmaceuticals (RARX) Price Target Raised to $42.00 at SunTrust Banks
www.americanbankingnews.com - May 17 at 11:15 AM
 Analysts Anticipate Ra Pharmaceuticals Inc (RARX) Will Announce Earnings of -$0.48 Per Share Analysts Anticipate Ra Pharmaceuticals Inc (RARX) Will Announce Earnings of -$0.48 Per Share
www.americanbankingnews.com - May 15 at 8:17 PM
Ra Pharmaceuticals (RARX) Announces  Earnings Results, Beats Estimates By $0.02 EPSRa Pharmaceuticals (RARX) Announces Earnings Results, Beats Estimates By $0.02 EPS
www.americanbankingnews.com - May 10 at 6:18 PM
Ra Pharmaceuticals (RARX) Presents At American Academy of Neurology Annual Meeting - SlideshowRa Pharmaceuticals (RARX) Presents At American Academy of Neurology Annual Meeting - Slideshow
seekingalpha.com - May 10 at 5:44 PM
Ra Pharma inks $100M stock sales deal with JefferiesRa Pharma inks $100M stock sales deal with Jefferies
seekingalpha.com - May 10 at 9:44 AM
Hedge Funds Have Never Been This Bullish On Ra Pharmaceuticals, Inc. (RARX)Hedge Funds Have Never Been This Bullish On Ra Pharmaceuticals, Inc. (RARX)
finance.yahoo.com - May 10 at 9:44 AM
Ra Pharmaceuticals Announces Positive gMG Phase 2 and Open-Label, Long-Term Extension Data at the 2019 AAN Annual MeetingRa Pharmaceuticals Announces Positive gMG Phase 2 and Open-Label, Long-Term Extension Data at the 2019 AAN Annual Meeting
finance.yahoo.com - May 7 at 9:38 AM
Ra Pharmaceuticals Inc (RARX) Given Average Recommendation of "Buy" by BrokeragesRa Pharmaceuticals Inc (RARX) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - April 28 at 4:53 AM
Ra Pharmaceuticals Presents Pre-Clinical Data for Zilucoplan XR at the 6th Annual Peptides CongressRa Pharmaceuticals Presents Pre-Clinical Data for Zilucoplan XR at the 6th Annual Peptides Congress
finance.yahoo.com - April 24 at 9:44 AM
Ra Pharmaceuticals Closes End-of-Phase 2 Interaction with FDARa Pharmaceuticals Closes End-of-Phase 2 Interaction with FDA
finance.yahoo.com - April 10 at 6:19 PM
Ra Pharma finalizing design of Phase 3 zilucoplan study in myasthenia gravis; shares up 2% premarketRa Pharma finalizing design of Phase 3 zilucoplan study in myasthenia gravis; shares up 2% premarket
seekingalpha.com - April 9 at 10:14 AM
Ra Pharmaceuticals Announces Completion of End-of-Phase 2 Interactions with FDA and Design of Pivotal Phase 3 gMG StudyRa Pharmaceuticals Announces Completion of End-of-Phase 2 Interactions with FDA and Design of Pivotal Phase 3 gMG Study
finance.yahoo.com - April 9 at 10:14 AM
Ra Pharmaceuticals Announces Acceptance of gMG Phase 2 and Open-Label, Long-Term Extension Data for Emerging Science Dual Presentation at the 2019 AAN Annual MeetingRa Pharmaceuticals Announces Acceptance of gMG Phase 2 and Open-Label, Long-Term Extension Data for Emerging Science Dual Presentation at the 2019 AAN Annual Meeting
finance.yahoo.com - April 1 at 5:51 PM
First Week of RARX May 17th Options TradingFirst Week of RARX May 17th Options Trading
www.nasdaq.com - March 21 at 6:07 PM
Winning Bounce/Lag Momentum Stocks For Week 11 Of 2019 (3/11-3/15)Winning Bounce/Lag Momentum Stocks For Week 11 Of 2019 (3/11-3/15)
seekingalpha.com - March 13 at 5:43 PM
Ra Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate UpdateRa Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - March 7 at 10:29 AM
Ra Pharmaceuticals to Present at the Cowen 39th Annual Health Care ConferenceRa Pharmaceuticals to Present at the Cowen 39th Annual Health Care Conference
finance.yahoo.com - March 4 at 10:19 AM
5 Clinical Stage Biotech Stocks to Buy5 Clinical Stage Biotech Stocks to Buy
investorplace.com - February 25 at 3:36 PM
Ra Pharmaceuticals to Present at the 8th Annual SVB Leerink Global Healthcare ConferenceRa Pharmaceuticals to Present at the 8th Annual SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 21 at 10:26 AM
Ra Pharma: How Good Is The Phase 2 Myasthenia Gravis Study?Ra Pharma: How Good Is The Phase 2 Myasthenia Gravis Study?
seekingalpha.com - December 24 at 9:23 AM
Hedge Funds Are Betting On Ra Pharmaceuticals, Inc. (RARX)Hedge Funds Are Betting On Ra Pharmaceuticals, Inc. (RARX)
finance.yahoo.com - December 20 at 4:40 PM
Ra Pharmaceuticals prices common stock offeringRa Pharmaceuticals prices common stock offering
seekingalpha.com - December 12 at 5:00 PM
Ra Pharmaceuticals (RARX) Announces Proposed $100M Public Offering of Common StockRa Pharmaceuticals (RARX) Announces Proposed $100M Public Offering of Common Stock
www.streetinsider.com - December 10 at 4:35 PM
Ra Pharmaceuticals Inc.Ra Pharmaceuticals Inc.
www.barrons.com - December 10 at 4:35 PM
Ra Pharmaceuticals Delivers on Midstage Muscle StudyRa Pharmaceuticals Delivers on Midstage Muscle Study
247wallst.com - December 10 at 4:35 PM
Ra Pharma readies $100M stock offering; shares down 2% after hoursRa Pharma readies $100M stock offering; shares down 2% after hours
seekingalpha.com - December 10 at 4:35 PM
Alexion Pharma (ALXN) Could Consider Buying Ra Pharmaceuticals (RARX) Outright - RBCAlexion Pharma (ALXN) Could Consider Buying Ra Pharmaceuticals (RARX) Outright - RBC
www.streetinsider.com - December 10 at 4:35 PM
Ra Pharma Shares Rally: What You Need To KnowRa Pharma Shares Rally: What You Need To Know
www.benzinga.com - December 10 at 4:35 PM
Heres Why Ra Pharmaceuticals Inc. Is Soaring TodayHere's Why Ra Pharmaceuticals Inc. Is Soaring Today
www.fool.com - December 10 at 3:39 PM
Ra Pharmas zilucoplan shows positive effect in mid-stage myasthenia gravis study; shares up 17% premarketRa Pharma's zilucoplan shows positive effect in mid-stage myasthenia gravis study; shares up 17% premarket
seekingalpha.com - December 10 at 9:26 AM
Ra Pharmaceuticals Announces Positive Top-line Data from Phase 2 Trial of Zilucoplan in Patients with Generalized Myasthenia GravisRa Pharmaceuticals Announces Positive Top-line Data from Phase 2 Trial of Zilucoplan in Patients with Generalized Myasthenia Gravis
finance.yahoo.com - December 10 at 9:26 AM
BRIEF-Ra Pharmaceuticals Receives Development Milestone Payment Under Agreement With MerckBRIEF-Ra Pharmaceuticals Receives Development Milestone Payment Under Agreement With Merck
www.msn.com - December 6 at 9:26 AM
Ra Pharmaceuticals Receives Development Milestone Payment Under Agreement with MerckRa Pharmaceuticals Receives Development Milestone Payment Under Agreement with Merck
finance.yahoo.com - December 6 at 9:26 AM
Ra Pharmaceuticals Elects Bo Cumbo to Board of DirectorsRa Pharmaceuticals Elects Bo Cumbo to Board of Directors
finance.yahoo.com - November 15 at 9:24 AM
ADDING and REPLACINGRa Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate UpdateADDING and REPLACINGRa Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update
www.marketwatch.com - November 8 at 4:32 PM
Ra Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate UpdateRa Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - November 7 at 4:35 PM
Can the Rally in Ra Pharmaceuticals (RARX) Shares Continue?Can the Rally in Ra Pharmaceuticals (RARX) Shares Continue?
www.zacks.com - September 28 at 9:27 AM
Ra Pharmaceuticals (RARX) Reports Positive Results from Phase 1b Pharmacokinetic Study of Zilucoplan (RA101495 SC) in Patients with Renal ImpairmentRa Pharmaceuticals (RARX) Reports Positive Results from Phase 1b Pharmacokinetic Study of Zilucoplan (RA101495 SC) in Patients with Renal Impairment
www.streetinsider.com - September 27 at 9:28 AM
Ra Pharmas zilucoplan shows favorable PK profile in renal impairment patients, expanding potential clinical programsRa Pharma's zilucoplan shows favorable PK profile in renal impairment patients, expanding potential clinical programs
seekingalpha.com - September 26 at 9:46 AM
Ra Pharma Announces Positive Results from Phase 1b Pharmacokinetic Study of Zilucoplan (RA101495 SC) in Patients with Renal ImpairmentRa Pharma Announces Positive Results from Phase 1b Pharmacokinetic Study of Zilucoplan (RA101495 SC) in Patients with Renal Impairment
finance.yahoo.com - September 26 at 9:46 AM
Ra Pharmaceuticals to Present at the 2018 Cantor Global Healthcare ConferenceRa Pharmaceuticals to Present at the 2018 Cantor Global Healthcare Conference
finance.yahoo.com - September 25 at 4:19 PM
Ra Pharma Elects Aoife M. Brennan, M.B., B.Ch., to Board of DirectorsRa Pharma Elects Aoife M. Brennan, M.B., B.Ch., to Board of Directors
finance.yahoo.com - September 25 at 9:30 AM
Ra Pharma completes End-of-Phase 2 interactions with FDA and design of Phase 3 PNH programRa Pharma completes End-of-Phase 2 interactions with FDA and design of Phase 3 PNH program
seekingalpha.com - September 5 at 9:41 AM
Ra Pharma Announces Completion of End-of-Phase 2 Interactions with FDA and Design of Phase 3 PNH ProgramRa Pharma Announces Completion of End-of-Phase 2 Interactions with FDA and Design of Phase 3 PNH Program
finance.yahoo.com - September 5 at 9:41 AM
Ra Pharmaceuticals Reports Second Quarter 2018 Financial Results and Announces Early Completion of Enrollment in gMG Phase 2 ProgramRa Pharmaceuticals Reports Second Quarter 2018 Financial Results and Announces Early Completion of Enrollment in gMG Phase 2 Program
finance.yahoo.com - August 8 at 9:45 AM
Ra Pharmaceuticals: Is Trying To Copy What Works A Good Product Development Strategy?Ra Pharmaceuticals: Is Trying To Copy What Works A Good Product Development Strategy?
seekingalpha.com - July 31 at 9:50 AM
Ra Pharmaceuticals Presents Data on Oral, Small Molecule Complement Inhibitors and Phase 2 RA101495 SC Program in PNH at the 23 rd Congress of the European Hematology AssociationRa Pharmaceuticals Presents Data on Oral, Small Molecule Complement Inhibitors and Phase 2 RA101495 SC Program in PNH at the 23 rd Congress of the European Hematology Association
www.businesswire.com - June 15 at 9:21 AM
Ra Pharmaceuticals Presents Data on Oral, Small Molecule Complement Inhibitors and Phase 2 RA101495 SC Program in PNH at the 23rd Congress of the European Hematology AssociationRa Pharmaceuticals Presents Data on Oral, Small Molecule Complement Inhibitors and Phase 2 RA101495 SC Program in PNH at the 23rd Congress of the European Hematology Association
finance.yahoo.com - June 15 at 9:21 AM
Ra Pharmaceuticals to Present at the 4th Congress of the European Academy of NeurologyRa Pharmaceuticals to Present at the 4th Congress of the European Academy of Neurology
finance.yahoo.com - June 5 at 9:15 AM
Ra Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare ConferenceRa Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare Conference
finance.yahoo.com - May 31 at 9:53 AM
This page was last updated on 5/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel